← Back to Search

ATTACH™ Parenting Program for Parent-Child Relationship (ATTACH™ Trial)

N/A

Recruiting

Led By Nicole Letourneau, PhD RN FCAHS

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline pcits scores after completion of intervention and at 3 months.

Awards & highlights

No Placebo-Only Group

Summary

This trial sought to test the efficacy of the ATTACH parenting intervention in reducing stress-related health problems in children. The study found that ATTACH was successful in reducing stress and improving health outcomes for children. However, the study was limited by its small sample size and lack of long-term data.

Who is the study for?

The ATTACH™ Program is for parents with children from birth to 32 months who are dealing with toxic stress factors like depression, addictions, or poverty. Parents must commit to weekly training sessions for 10-12 weeks and agree to bring a co-parent when possible. They also need to consent to blood sample collection in certain locations.

What is being tested?

This trial tests the ATTACH™ Parenting Program's effectiveness when delivered by healthcare professionals in community settings. It aims at improving parent-child relationships and child development outcomes by enhancing parents' understanding of thoughts and feelings (reflective function).

What are the potential side effects?

Since ATTACH™ is an educational program rather than a medical treatment, it doesn't have side effects like drugs do. However, participants may experience emotional discomfort or distress while reflecting on personal experiences during the program.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline prfq scores after completion of intervention and at 3 months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline prfq scores after completion of intervention and at 3 months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline prfq scores after completion of intervention and at 3 months. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Parent-Child Relationship Quality will be measured by Parent Child Interaction Teaching Scale (PCITS).

Secondary study objectives

Child Development, measured by Ages and Stages Questionnaire - 3rd Edition

Parental Reflective Function will be measured by Parental Reflective Function Questionnaire (PRFQ).

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Intervention groupExperimental Treatment1 Intervention

* A quasi-experimental design was selected to more closely approximate service delivery models in agencies that do not typically employ control groups. * Given promising findings (from seven ATTACH™ pilot studies), a randomized controlled trial design, even employing wait-list controls was deemed unacceptable and even unethical by patients, health care professionals and health system administrators in engagement activities surrounding the preparation of this proposal.

Do I qualify?Apply below to find out